Montana 2025 Regular Session

Montana House Bill HB608 Latest Draft

Bill / Introduced Version

                            **** 
69th Legislature 2025 	HB 608.1
- 1 - Authorized Print Version – HB 608 
1 HOUSE BILL NO. 608
2 INTRODUCED BY K. SEEKINS-CROWE
3
4 A BILL FOR AN ACT ENTITLED: “AN ACT REQUIRING THE CANNABIS CONTROL DIVISION TO 
5 REGULATE ALL PRODUCTS THAT CONTAIN TETRAHYDROCANNABINOL (THC); PROVIDING 
6 DEFINITIONS; PROVIDING RULEMAKING AUTHORITY; AMENDING SECTIONS 16-12-102 AND 16-12-112, 
7 MCA; AND PROVIDING AN IMMEDIATE EFFECTIVE DATE.”
8
9 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:
10
11 NEW SECTION. Section 1.  The cannabis control 
12 division of the department of revenue shall regulate THC products, which may include but are not limited to 
13 testing, licensing, distribution, sale, and taxation.
14
15 Section 16-12-102, MCA, is amended to read:
16 "16-12-102.  As used in this chapter, the following definitions apply:
17 (1) "Adult-use dispensary" means a licensed premises from which a person licensed by the 
18 department may:
19 (a) obtain marijuana or marijuana products from a licensed cultivator, manufacturer, dispensary, or 
20 other licensee approved under this chapter; and
21 (b) sell marijuana or marijuana products to registered cardholders, adults that are 21 years of age 
22 or older, or both.
23 (2) "Affiliate" means a person that directly, or indirectly through one or more intermediaries, 
24 controls or is controlled by, or is under common control with, another person.
25 (3) "Beneficial owner of", "beneficial ownership of", or "beneficially owns an" is determined in 
26 accordance with section 13(d) of the federal Securities and Exchange Act of 1934, as amended.
27 (4) "Canopy" means the total amount of square footage dedicated to live plant production at a 
28 licensed premises consisting of the area of the floor, platform, or means of support or suspension of the plant. **** 
69th Legislature 2025 	HB 608.1
- 2 - Authorized Print Version – HB 608 
1 (5) "Consumer" means a person 21 years of age or older who obtains or possesses marijuana or 
2 marijuana products for personal use from a licensed dispensary but not for resale.
3 (6) "Control", "controls", "controlled", "controlling", "controlled by", and "under common control 
4 with" mean the possession, direct or indirect, of the power to direct or cause the direction of the management or 
5 policies of a person, whether through the ownership of voting owner's interests, by contract, or otherwise.
6 (7) "Controlling beneficial owner" means a person that satisfies one or more of the following:
7 (a) is a natural person, an entity that is organized under the laws of and for which its principal 
8 place of business is located in one of the states or territories of the United States or District of Columbia, or a 
9 publicly traded corporation, and:
10 (i) acting alone or acting in concert, owns or acquires beneficial ownership of 5% or more of the 
11 owner's interest of a marijuana business;
12 (ii) is an affiliate that controls a marijuana business and includes, without limitation, any manager; 
13 or
14 (iii) is otherwise in a position to control the marijuana business; or
15 (b) is a qualified institutional investor acting alone or acting in concert that owns or acquires 
16 beneficial ownership of more than 15% of the owner's interest of a marijuana business.
17 (8) "Correctional facility or program" means a facility or program that is described in 53-1-202(2) or 
18 (3) and to which an individual may be ordered by any court of competent jurisdiction.
19 (9) "Cultivator" means a person licensed by the department to:
20 (a) plant, cultivate, grow, harvest, and dry marijuana; and
21 (b) package and relabel marijuana produced at the location in a natural or naturally dried form that 
22 has not been converted, concentrated, or compounded for sale through a licensed dispensary.
23 (10) "Debilitating medical condition" means:
24 (a) cancer, glaucoma, positive status for human immunodeficiency virus, or acquired immune 
25 deficiency syndrome when the condition or disease results in symptoms that seriously and adversely affect the 
26 patient's health status;
27 (b) cachexia or wasting syndrome;
28 (c) severe chronic pain that is a persistent pain of severe intensity that significantly interferes with  **** 
69th Legislature 2025 	HB 608.1
- 3 - Authorized Print Version – HB 608 
1 daily activities as documented by the patient's treating physician;
2 (d) intractable nausea or vomiting;
3 (e) epilepsy or an intractable seizure disorder;
4 (f) multiple sclerosis;
5 (g) Crohn's disease;
6 (h) painful peripheral neuropathy;
7 (i) a central nervous system disorder resulting in chronic, painful spasticity or muscle spasms;
8 (j) admittance into hospice care in accordance with rules adopted by the department; or
9 (k) posttraumatic stress disorder.
10 (11) "Department" means the department of revenue provided for in 2-15-1301.
11 (12) (a) "Employee" means an individual employed to do something for the benefit of an employer.
12 (b) The term includes a manager, agent, or director of a partnership, association, company, 
13 corporation, limited liability company, or organization.
14 (c) The term does not include a third party with whom a licensee has a contractual relationship.
15 (13) (a) "Financial interest" means a legal or beneficial interest that entitles the holder, directly or 
16 indirectly through a business, an investment, or a spouse, parent, or child relationship, to 5% or more of the net 
17 profits or net worth of the entity in which the interest is held.
18 (b) The term does not include interest held by a bank or licensed lending institution or a security 
19 interest, lien, or encumbrance but does include holders of private loans or convertible securities.
20 (14) "Former medical marijuana licensee" means a person that was licensed by or had an 
21 application for licensure pending with the department of public health and human services to provide marijuana 
22 to individuals with debilitating medical conditions on April 27, 2021.
23 (15) (a) "Hemp" means the plant species Cannabis sativa L. and any part of that plant, including the 
24 seeds and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing 
25 or not.
26 (b) The term does not include synthetic cannabinoids.
27 (16) "Hemp product" means a defined group of postharvest products that contain hemp. The term 
28 includes: **** 
69th Legislature 2025 	HB 608.1
- 4 - Authorized Print Version – HB 608 
1 (a) hemp concentrates;
2 (b) hemp-infused products, including ingestible hemp-infused products that are edible or 
3 transmucosal; and
4 (c) nonedible hemp-infused products that are topical or transdermal.
5 (15)(17)(a) "Indoor cultivation facility" means an enclosed area used to grow live plants that is within a 
6 permanent structure using artificial light exclusively or to supplement natural sunlight.
7 (b) The term may include:
8 (i) a greenhouse; or
9 (ii) a similar structure that protects the plants from variable temperature, precipitation, and wind.
10 (16)(18)"Licensed premises" means all locations related to, or associated with, a specific license that is 
11 authorized under this chapter and includes all enclosed public and private areas at the location that are used in 
12 the business operated pursuant to a license, including offices, kitchens, restrooms, and storerooms.
13 (17)(19)"Licensee" means a person holding a state license issued pursuant to this chapter.
14 (18)(20)"Local government" means a county, a consolidated government, or an incorporated city or 
15 town.
16 (19)(21)"Manufacturer" means a person licensed by the department to convert or compound marijuana 
17 into marijuana products, marijuana concentrates, or marijuana extracts and package, repackage, label, or 
18 relabel marijuana products as allowed under this chapter.
19 (20)(22)(a) "Marijuana" means all plant material from the genus Cannabis containing 
20 tetrahydrocannabinol (THC) or seeds of the genus capable of germination.
21 (b) The term does not include hemp as provided in 80-18-101.
22 (c) The term does not include synthetic marijuana products.
23 (d) The term does not include a drug approved by the United States food and drug administration 
24 pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301, et seq.
25 (21)(23)"Marijuana business" means a cultivator, manufacturer, adult-use dispensary, medical 
26 marijuana dispensary, combined-use marijuana licensee, testing laboratory, marijuana transporter, or any other 
27 business or function that is licensed by the department under this chapter.
28 (22)(24)"Marijuana concentrate" means any type of marijuana product consisting wholly or in part of the  **** 
69th Legislature 2025 	HB 608.1
- 5 - Authorized Print Version – HB 608 
1 resin extracted from any part of the marijuana plant.
2 (23)(25)"Marijuana derivative" means any mixture or preparation of the dried leaves, flowers, resin, or 
3 byproducts of the marijuana plant, including but not limited to marijuana concentrates and other marijuana 
4 products.
5 (24)(26)"Marijuana product" means a product that contains marijuana and is intended for use by a 
6 consumer. The term includes but is not limited to edible products, ointments, tinctures, marijuana derivatives, 
7 and marijuana concentrates, including concentrates intended for use by smoking or vaping.
8 (25)(27)"Marijuana transporter" means a person that is licensed to transport marijuana and marijuana 
9 products from one marijuana business to another marijuana business, or to and from a testing laboratory, and 
10 to temporarily store the transported retail marijuana and retail marijuana products at its licensed premises, but 
11 is not authorized to sell marijuana or marijuana products to consumers under any circumstances.
12 (26)(28)"Mature marijuana plant" means a harvestable marijuana plant.
13 (27)(29)"Medical marijuana" means marijuana or marijuana products that are for sale solely to a 
14 cardholder who is registered under Title 16, chapter 12, part 5.
15 (28)(30)"Medical marijuana dispensary" means the location from which a registered cardholder may 
16 obtain marijuana or marijuana products.
17 (29)(31)"Outdoor cultivation" means live plants growing in an area exposed to natural sunlight and 
18 environmental conditions including variable temperature, precipitation, and wind.
19 (30)(32)"Owner's interest" means the shares of stock in a corporation, a membership in a nonprofit 
20 corporation, a membership interest in a limited liability company, the interest of a member in a cooperative or in 
21 a limited cooperative association, a partnership interest in a limited partnership, a partnership interest in a 
22 partnership, and the interest of a member in a limited partnership association.
23 (31)(33)"Paraphernalia" has the meaning provided for "drug paraphernalia" in 45-10-101.
24 (32)(34)"Passive beneficial owner" means any person acquiring an owner's interest in a marijuana 
25 business that is not otherwise a controlling beneficial owner or in control.
26 (33)(35)"Person" means an individual, partnership, association, company, corporation, limited liability 
27 company, or organization.
28 (34)(36)"Qualified institutional investor" means: **** 
69th Legislature 2025 	HB 608.1
- 6 - Authorized Print Version – HB 608 
1 (a) a bank or banking institution including any bank, trust company, member bank of the federal 
2 reserve system, bank and trust company, stock savings bank, or mutual savings bank that is organized and 
3 doing business under the laws of this state, any other state, or the laws of the United States;
4 (b) a bank holding company as defined in 32-1-109;
5 (c) a company organized as an insurance company whose primary and predominant business 
6 activity is the writing of insurance or the reinsuring of risks underwritten by insurance companies, and that is 
7 subject to regulation or oversight by the insurance department of the office of the state auditor or a similar 
8 agency of another state, or any receiver or similar official or any liquidating agent for such a company, in their 
9 capacity as such an insurance company;
10 (d) an investment company registered under section 8 of the federal Investment Company Act of 
11 1940, as amended;
12 (e) an employee benefit plan or pension fund subject to the federal Employee Retirement Income 
13 Security Act of 1974, excluding an employee benefit plan or pension fund sponsored by a licensee or an 
14 intermediary holding company licensee that directly or indirectly owns 10% or more of a licensee;
15 (f) a state or federal government pension plan; or
16 (g) any other entity identified by rule by the department.
17 (35)(37)"Registered cardholder" or "cardholder" means a Montana resident with a debilitating medical 
18 condition who has received and maintains a valid registry identification card.
19 (36)(38)"Registry identification card" means a document issued by the department pursuant to 16-12-
20 503 that identifies an individual as a registered cardholder.
21 (37)(39)(a) "Resident" means an individual who meets the requirements of 1-1-215.
22 (b) An individual is not considered a resident for the purposes of this chapter if the individual:
23 (i) claims residence in another state or country for any purpose; or
24 (ii) is an absentee property owner paying property tax on property in Montana.
25 (38)(40)"Seedling" means a marijuana plant that has no flowers and is less than 12 inches in height 
26 and 12 inches in diameter.
27 (39)(41)"Synthetic cannabinoids" has the meaning provided in 50-32-222 and includes any 
28 cannabinoids produced artificially, whether from chemical synthesis or biosynthesis using recombinant  **** 
69th Legislature 2025 	HB 608.1
- 7 - Authorized Print Version – HB 608 
1 biological agents, including but not limited to yeast and algae.
2 (40)(42)"Synthetic marijuana product" means marijuana or marijuana products that contain synthetic 
3 cannabinoids.
4 (41)(43)"Testing laboratory" means a qualified person, licensed under this chapter that:
5 (a) provides testing of representative samples of marijuana and marijuana products; and
6 (b) provides information regarding the chemical composition and potency of a sample, as well as 
7 the presence of molds, pesticides, or other contaminants in a sample.
8 (44) (a) "THC product" means a product that contains natural delta-9 tetrahydrocannabinol (THC) in 
9 any form or any concentration and from any source that is intended for any method of administration.
10 (b) The term includes but is not limited to products containing natural delta-9 THC, such as 
11 marijuana and marijuana products, hemp products, and products naturally derived from the plant cannabis 
12 family Cannabaceae intended for consumption, smoking, vaping, application to the skin, or another method of 
13 administration.
14 (42)(45)(a) "Usable marijuana" means the dried leaves and flowers of the marijuana plant that are 
15 appropriate for the use of marijuana by an individual.
16 (b) The term does not include the seeds, stalks, and roots of the plant."
17
18 Section 16-12-112, MCA, is amended to read:
19 "16-12-112.  (1) The department may adopt rules to implement and 
20 administer this chapter, including:
21 (a) the manner in which the department will consider applications for licenses, permits, and 
22 endorsements and renewal of licenses, permits, and endorsements;
23 (b) the acceptable forms of proof of Montana residency;
24 (c) the procedures for obtaining fingerprints for the fingerprint-based and name-based background 
25 checks required under 16-12-129;
26 (d) the security and operating requirements for licensees;
27 (e) the security and operating requirements for manufacturing, including but not limited to 
28 requirements for: **** 
69th Legislature 2025 	HB 608.1
- 8 - Authorized Print Version – HB 608 
1 (i) safety equipment;
2 (ii) extraction methods, including solvent-based and solvent-free extraction; and
3 (iii) post-processing procedures;
4 (f) notice and contested case hearing procedures for fines or license and endorsement 
5 revocations, suspensions, or modifications;
6 (g) implementation of a system to allow the tracking of marijuana and marijuana products as 
7 required by 16-12-105;
8 (h) labeling and packaging standards that protect public health by requiring the listing of 
9 pharmacologically active ingredients, including but not limited to THC, cannabidiol (CBD) and other cannabinoid 
10 content, the THC and other cannabinoid amount in milligrams per serving, the number of servings per package, 
11 and quantity limits per sale to comply with the allowable possession amount;
12 (i) investigating and making rules to limit, if necessary, the appropriate THC potency percentages 
13 for marijuana and marijuana products;
14 (j) requirements that packaging and labels may not be made to be attractive to children, that they 
15 have required warning labels as set forth in 16-12-215, and that marijuana and marijuana products be sold in 
16 resealable, child-resistant exit packaging to protect public health as provided in 16-12-208;
17 (k) requirements and standards for the testing and retesting of marijuana and marijuana products, 
18 including testing of samples collected during the department's inspections of licensed premises;
19 (l) the amount of variance allowable in the results of raw testing data that would warrant a 
20 departmental investigation of inconsistent results as provided in 16-12-202;
21 (m) requirements and standards to prohibit or limit marijuana, marijuana products, and marijuana 
22 accessories that are unsafe or contaminated;
23 (n) the activities that constitute advertising in violation of 16-12-211 and requirements and 
24 standards for electronic advertising as permitted under 16-12-211;
25 (o) requirements and incentives to promote renewable energy, reduce water usage, and reduce 
26 packaging waste to maintain a clean and healthy environment in Montana;
27 (p) procedures for collecting and destroying samples of marijuana and marijuana products that fail 
28 to meet testing requirements pursuant to 16-12-209; and **** 
69th Legislature 2025 	HB 608.1
- 9 - Authorized Print Version – HB 608 
1 (q) the fees for testing laboratories, the fingerprint-based and name-based background checks 
2 required under 16-12-129, employee certification, the marijuana transporter license, marijuana worker permits, 
3 and other fees necessary to administer and enforce the provisions of this chapter. The fees established by the 
4 department, taxes collected pursuant to Title 15, chapter 64, part 1, civil penalties imposed pursuant to this 
5 chapter, and the licensing fees established by rule and in part 2 of this chapter must be sufficient to offset the 
6 expenses of administering this chapter but may not exceed the amount necessary to cover the costs to the 
7 department of implementing and enforcing this chapter.
8 (r) the regulation of THC products pursuant to [section 1].
9 (2) The department may not adopt any rule or regulation that is unduly burdensome or undermines 
10 the purposes of this chapter.
11 (3) The department may consult or contract with other public agencies in carrying out its duties 
12 under this chapter."
13
14 NEW SECTION. Section 4.  [Section 1] is intended to be codified as an 
15 integral part of Title 16, chapter 12, part 1, and the provisions of Title 16, chapter 12, part 1, apply to [section 1].
16
17 NEW SECTION. Section 5.  [This act] is effective on passage and approval.
18 - END -